XML 37 R32.htm IDEA: XBRL DOCUMENT
v3.26.1

Collaboration and license agreements (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Summary of deferred revenue amounts allocated to performance obligations | The following table summarizes the deferred revenue amounts allocated to the Roche Agreement performance obligations (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2026 |  |  | 2025 |
Roche Agreement performance obligations |  |  |  |  |  |
Research and development of initial targets |  | $ | 7,180 |  |  | $ | 14,140 |
Research and development for replacement targets |  |  | 7,999 |  |  |  | 8,517 |
Total Roche Agreement deferred revenue |  | $ | 15,179 |  |  | $ | 22,657 |
Schedule of Transaction Price Allocated To Performance Obligations | The following table summarizes the unearned amount of the 2025 Novartis Agreement transaction price allocated to the performance obligations (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2026 |  |  | 2025 |
2025 Novartis Agreement performance obligations |  |  |  |  |  |
License and research services for named immunology target |  | $ | 6,558 |  |  | $ | 7,019 |
Research services to support immunology license options |  |  | 80,458 |  |  |  | 85,698 |
Material right - first immunology license option |  |  | 49,091 |  |  |  | 49,091 |
Material right - second immunology license option |  |  | 36,439 |  |  |  | 36,439 |
Total unearned amount of transaction price |  | $ | 172,546 |  |  | $ | 178,247 |

X
- Definition Schedule of Transaction Price Allocated To Performance Obligations [Table Text Block] + References No definition available. + Details
Name: | glue_ScheduleOfTransactionPriceAllocatedToPerformanceObligationsTableTextBlock
Namespace Prefix: | glue_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date. + References No definition available. + Details
Name: | us-gaap_DeferredRevenueByArrangementDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration